{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:57:42Z","timestamp":1781769462153,"version":"3.54.5"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"DOI":"10.1093\/cid\/cis340","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T16:19:01Z","timestamp":1341245941000},"page":"S149-S153","source":"Crossref","is-referenced-by-count":72,"title":["Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis"],"prefix":"10.1093","volume":"55","author":[{"given":"Martijn P.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein P. M.","family":"Hensgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale N.","family":"Gerding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren N.","family":"Fawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed J.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwood L.","family":"Gorbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"key\n\t\t\t\t20171014012447_CIS340C1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2008.12.038","article-title":"Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection","volume":"136","author":"Hu","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171014012447_CIS340C2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/658336","article-title":"Comparison of clinical severity score indices for Clostridium difficile infection","volume":"32","author":"Fujitani","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171014012447_CIS340C3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3201\/eid1503.080312","article-title":"Clinical risk factors for severe Clostridium difficile-associated disease","volume":"15","author":"Henrich","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014012447_CIS340C4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/510391","article-title":"A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Qu\u00e9bec","volume":"44","author":"Hubert","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014012447_CIS340C5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/649213","article-title":"Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality","volume":"50","author":"Miller","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014012447_CIS340C6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","article-title":"Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity","volume":"171","author":"P\u00e9pin","year":"2004","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20171014012447_CIS340C7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171014012447_CIS340C8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)","volume":"15","author":"Bauer","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171014012447_CIS340C9","article-title":"Efficacy and safety of fidaxomicin (FDX) vs vancomycin (VAN) in Clostridium difficile infection (CDI) in 2 randomized controlled trials (RCT) with 1105 patients [abstract 1417]","author":"Crook"},{"key":"key\n\t\t\t\t20171014012447_CIS340C10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014012447_CIS340C11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1463-1318.2006.01013.x","article-title":"Risk factors for severity and relapse of pseudomembranous colitis in an elderly population","volume":"9","author":"Moshkowitz","year":"2007","journal-title":"Colorectal Dis"},{"key":"key\n\t\t\t\t20171014012447_CIS340C12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014012447_CIS340C13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archsurg.2009.51","article-title":"Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality","volume":"144","author":"Sailhamer","year":"2009","journal-title":"Arch Surg"},{"key":"key\n\t\t\t\t20171014012447_CIS340C14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jinf.2007.09.015","article-title":"Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system","volume":"55","author":"Belmares","year":"2007","journal-title":"J Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/55\/suppl_2\/S149\/20910993\/cis340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T01:24:54Z","timestamp":1507944294000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/55\/suppl_2\/S149\/435669\/Renal-Failure-and-Leukocytosis-Are-Predictors-of-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":14,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2012,8,1]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis340","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,8,1]]},"published":{"date-parts":[[2012,8,1]]}}}